Country Profile: Czechia

Recommendations

Children:
Children aged 3 to 13 months​

At-risk groups:
At-risk groups aged 2-64, including chronic lung disease (includes moderate and severe bronchial asthma), with long-term medical treatment; persons with heart disease and/or large vessels with long-term systemic medical treatment, such as hypertension; people with chronic kidney and liver disease; patients with diabetes mellitus; patients with an immune disorder system (eg patients with immunosuppressive treatment (steroids, HIV infections, etc.) and asplenia / hyposplenia; patients with anticancer treatment; patients before / after solid organ and / or bone marrow transplantation; people with severe obesity (BMI over 40 kg / m2)

Older adults:
All people over the age of 65

Coverage figures

Children: 82.00% (2021)

At-risk groups: 4.00%1 (2016)

Older adults: 4.00%2 (2017)

Vaccination advisory body/committee

National Immunization Commission (Národní imunizační komise)

Visit website

 

Notes:

1 Figure taken from Ipsos Healthcare survey based on interviews with 1002 people aged 50 years and over.

2 Figure taken from Ipsos Healthcare survey based on interviews with 468 people aged 65 years and over.

Report an issue: Something doesn’t look right? Contact us